Stevanato Group Announces Voting Results from its Annual General Meeting
businesswire.com
news
2022-06-02 00:00:00

June 02, 2022 04:05 PM Eastern Daylight Time PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that all resolutions proposed to Shareholders at the Annual General Meeting of Shareholders ('AGM') held virtually on June 1, 2022 were passed.

Details of the resolutions submitted to, and approved by, the AGM are included in the explanatory report prepared by the board of directors of the Company, which is available on the Company's corporate website at https://ir.
